Search

everythinglearnresearchcommunity

for

Search:↓

SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Gene variation affects prostate issues and hair loss.

PRP therapy can improve hair growth in early to moderate hair loss but needs standardized methods for consistent results.

PRP is a promising treatment for hair loss.

PRP treatment can increase hair growth in male pattern baldness, but this effect is not linked to the levels of growth factors or the number of platelets.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

SVF-PRP therapy effectively reverses hair loss effects.

Personalized treatments for hair loss are becoming more effective by using genetic information.

GPR40 agonists help hair growth through the protein ANGPTL4.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

PRP therapy is a promising and effective treatment for hair loss with minimal side effects.

PRP therapy is promising for hair loss but needs standardized methods and personalization.

Women with hair loss have more androgen receptors in certain hair follicles.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.

Injectable platelet-rich fibrin effectively improves hair density and scalp symptoms in androgenetic alopecia.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

Alopecia patients have less GPER-1, which might affect hair loss.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Platelet Rich Plasma (PRP) treatment effectively reduces hair fall and increases hair growth in patients with Androgenetic Alopecia (AGA), but it may cause pain.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Androgen receptor differences may contribute to hair loss in AGA patients.